Novo Nordisk’s Wegovy weight loss pill has a strong launch—and other reasons the stock is rising

Britain’s regulator approves a dose of up to 7.2 mg of semaglutide per week, up from 2.4 mg.
Morningstar

Novo Nordisk Down Nearly 7%, on Track for Lowest Close Since July 2021 — Data Talk

--Down 48.34% year-to-date; on pace for worst year since 1984, when it fell 57.59% --Down 69.75% from its all-time closing high of $146.91 on June 25, 2024 --Down 57.50% from 52 weeks ago (Nov. 25, ...